Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2400087479Phase 4Not yet recruiting
Phase 4, randomised trial in postoperative delirium (POD) comparing intraoperative niacinamide with Control: intraoperative placebo (2 arms). Primary endpoint: Incidence of postoperative delirium. Planned start Jul 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2400087479.